DSI (US Agent Services)

Acumen Fiscal Agent

Regulatory consulting firm providing FDA U.S. Agent services for foreign establishments, including registration, listing, communication with FDA, and inspection / compliance support.

DSI (DS InPharmatics) provides FDA U.S. Agent services for international pharmaceutical companies and other FDA-regulated products. They act as the required point of contact between foreign establishments and the FDA, handling establishment registration, product listing, regulatory communications, inspection coordination, and compliance support. DSI serves as your trusted U.S. Agent, ensuring adherence to all relevant FDA regulations and serving as a dependable liaison between your organization and the FDA.

About

**Who they are**
DSI (US Agent Services), a ProductLife Group company, is a regulatory, technical, and project management consulting firm established in 2007. They specialize in providing services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.

**Expertise & scope**
* Assisting global sponsors with product development, regulatory compliance, and project management challenges.
* Contributing to investigational applications, New Drug Applications (NDAs/BLAs), and briefing book resources for collaborations with regulatory authorities like the EMA and US FDA.
* Providing expertise in regulatory affairs and Chemistry, Manufacturing, and Controls (CMC).
* Offering solutions for small molecules, biologics, veterinary medicine, and cellular and gene therapy products.
* Specializing in Phase-Appropriate Expertise, Due Diligence, Drug Substance Services, Analytical Services, Drug Product Services, Supply Chain Services, Quality Assurance, and Program Management.

**Reputation / proof points**
* Founded in 2007.
* Partnered with over 200 unique sponsors globally.
* Contributed efforts to more than 100 investigational applications.
* Contributed efforts to over 25 full and supported New Drug Applications (NDAs/BLAs).
* Became part of ProductLife Group in April 2021.

Additional information

DSI InPharmatics focuses on providing a real-world, field-tested viewpoint to guide new products from pre-IND enabling work through clinical trials to regulatory approvals and post-approval lifecycle maintenance. They emphasize open exchange of information and directness, offering authentic assessments, representative timelines, dependable technical advice, and truthful submissions based on current and forward-thinking regulatory strategies. Their approach is not one-size-fits-all, positioning them as an extension of a client's internal team.

Key Highlights

  • Founded in 2007, DSI has over a decade of experience assisting global sponsors with product development and regulatory compliance. Source
    “Founded in 2007 by Edward Narke and Anthony Durning... Over more than a decade since its founding, DSI has built a unique record of success, assisting global sponsors address product development, regulatory compliance, and project management challenges.”
  • Partnered with over 200 unique sponsors globally, contributing to over 100 investigational applications and 25+ NDAs/BLAs. Source
    “Over the last decade, we have partnered with more than 200 unique sponsors not only here in the US but globally, having contributed efforts to more than 100 investigational applications, 25 full and supported new Drug Application (NDAs/BLAs))”
  • Provides specialized consulting for pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products. Source
    “DSI provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.”
  • Offers expertise in Regulatory Affairs and Chemistry, Manufacturing, and Controls (CMC). Source
    “WHAT CAN DSI DO FOR YOU?; REGULATORYAFFAIRS; CHEMISTRY MANUFACTURING CONTROLS;”

Certifications & Trust Signals

  • Became part of ProductLife Group in April 2021, expanding global reach and resources. Source
    “In April 2021 we were thrilled to announce that DSI has just become part of ProductLife Group.”
  • Provides services across various product types including small molecules, biologics, veterinary medicine, and cellular and gene therapy. Source
    “SOLUTIONS SMALL MOLECULE BIOLOGICS CONSULTANTS VETERINARY MEDICINE SOLUTIONS CELLULAR AND GENE THERAPY”

Buyer Snapshot

Best for
  • Companies seeking regulatory and CMC consulting for pharmaceuticals, biopharmaceuticals, and cellular/gene therapies.
  • Emerging biotech firms needing support with product development and regulatory submissions.
  • Manufacturers and marketers of healthcare products requiring compliance expertise.
How engagement typically works
  • Direct and authentic assessment.
  • Collaborative approach, acting as an extension of the client's team.
  • Focus on pragmatic drug development experience combined with project management.
Typical deliverables
  • Regulatory strategy development.
  • CMC submission content.
  • Project management for drug development.
  • Due diligence reports.
  • Support for IND, NDA, and BLA applications.
Good to know
  • Best when clients require specialized regulatory and CMC expertise for complex healthcare products.
  • Suitable for companies navigating US FDA and EMA regulatory pathways.
HQ: Mesa, US
Languages: English
Timezones: America/New_York, America/Chicago, America/Denver, America/Los_Angeles
Claim status: Listed

Services & Capabilities

Best FDA US Agent Services | Compare & Get Quotes

Jurisdictions: US
Countries: US
Industries: Drugs, Pharmaceuticals
Portfolio: 26-100
Onboarding time: 1–3 days
Pricing model: Onboarding + annual retainer
Starting from: USD 950
Included services: FDA communications handling, Inspection scheduling coordination, Registration support, Annual renewal reminders
Product Type: drugs
Service Types: US Agent Services, FDA Registration/Listing Support, Inspection Support, FDA Submissions (510(k), PMA, IDE, etc.), Product/Device Listing, Regulatory Consulting

Additional us_agent_fda Details

Included Services Detailed
Designation support and onboarding checklist for foreign establishment U.S. Agent setup, FDA communications receipt, acknowledgment, and routing to your designated contacts, Inspection scheduling support and operational readiness escalation (when applicable), Annual registration renewal reminders and administrative coordination
Excluded Services
Acting as importer of record, Commercial distribution management, Legal representation in enforcement actions
Onboarding Steps
Engage early with regulatory authorities, develop a comprehensive regulatory strategy, streamline manufacturing and quality control.
Coverage Details
U.S.-based agent coverage with defined business-hours availability and escalation path (seed summary).
Product Types
Pharmaceuticals, Biopharmaceuticals, Cellular and Gene Therapy Products, Veterinary Drugs, Veterinary Biologics
Registration Support
Implied through regulatory affairs support, but not explicitly stated as 'establishment registration'.
US Entity State
Pennsylvania (based on P.O. Box address)
Recall Support
No explicit mention of FDA recall and field action support.
Inspection Support
Implied through compliance support.
Emergency Contact24x7
No explicit mention of 24/7 emergency contact availability.
Request quotes
⚡ Instant booking available
Appoint a Vetted FDA U.S. Agent in 2 Minutes
Compare DSI (US Agent Services) and other vetted providers — instant pricing, no RFQ needed.
Book now — instant pricing →
Cruxi - Regulatory Compliance Services